Michael R. Freeman

Targeting Key Players of Neuroendocrine Differentiation in Prostate Cancer

I. Encío, Mirja Rotinen, Irene Zamora, 2023, International journal of molecular sciences.

Zinc transporters in prostate cancer.

M. Hediger, M. Freeman, P. Anderle, 2013, Molecular aspects of medicine.

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer

C. Morrissey, I. Garraway, E. Mostaghel, 2023, bioRxiv.

Mechanisms governing lineage plasticity and metabolic reprogramming in cancer.

S. V. Venugopal, Michael R. Freeman, Stephen J. Freedland, 2024, Trends in cancer.

Genetic and biological drivers of prostate cancer disparities in Black men.

Robert M Figlin, Michael R. Freeman, Jun Gong, 2023, Nature reviews. Urology.

Profiling phagosome proteins identifies PD-L1 as a fungal-binding receptor.

Wei Yang, A. Chatterjee, Chen Qian, 2024, Nature.

ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer

C. Morrissey, I. Garraway, E. Mostaghel, 2024, Nucleic acids research.